Patent ID: 11890402

Abstract:
The invention relates to an extracorporeal blood treatment device for carrying out an extracorporeal blood treatment, in which blood flows in an extracorporeal blood circuit A through the blood chamber 2 of a dialyser 1 which is divided by a semi-permeable membrane 4 into the blood chamber 2 and a dialysate chamber 3. The invention further relates a method for monitoring the integrity of a dialyser 1. The blood treatment device provides a preparation mode in preparation for the blood treatment, in which the dialysate chamber 3 of the dialyser 1 (filter) is filled with a liquid, while the blood chamber 2 is not filled with blood, and a treatment mode following the preparation mode, in which blood is conveyed through the blood chamber 2. For monitoring the integrity of the dialyser 1, in the preparation mode the fluid system B including the dialysate chamber 3, or a portion of the fluid system including the dialysate chamber, is filled with a liquid. At this time, however, the blood chamber 2 is not filled with blood. After the membrane of the dialyser 1 has been wetted with liquid, liquid is removed from the fluid system B including the dialysate chamber 3 such that a low pressure p is established in the fluid system. The control and arithmetic unit 29 of the blood treatment device is so configured that the increase in the amount of the low pressure p, measured by means of a pressure measuring apparatus 34, in a given time interval is determined, and the leakage rate LR of the fluid system is determined from the increase in the amount of the low pressure in a given time interval and the compliance C of the fluid system B including the dialysate chamber 3. A lack of integrity of the dialyser is then concluded on the basis of the determined leakage rate LR.